SCHEMBL16425622

CC1[C@@H](O[C@H]2C(O)C(OS(=O)(=O)O)[C@H](O[C@@H]3C(COS(=O)(=O)O)O[C@H](C)C(C)[C@H]3O)O[C@H]2N=O)OC(COS(=O)(=O)O)[C@@H](O[C@@H]2OC(C(=O)O)[C@@H](O[C@H]3OC(COS(=O)(=O)O)[C@@H](C)[C@H](O)C3C)[C@H](O)C2O)[C@@H]1C

nearest known ligand 0.51

Predicted protein targets (top 20)

	gene	UniProt	supporting neighbours	confidence
▸	F10	P00742	4/20	0.51

▸	BDNF	P23560	3/20	0.42

▸	PTN	P21246	2/20	0.42

▸	MDK	P21741	2/20	0.42

▸	SERPINC1	P01008	2/20	0.40

▸	CXCL12	P48061	3/20	0.40

▸	CCL2	P13500	2/20	0.40

▸	CXCL10	P02778	1/20	0.40

▸	CXCL8	P10145	1/20	0.40

▸	CCL5	P13501	1/20	0.40

▸	BMP2	P12643	2/20	0.33

▸	VEGFA	P15692	2/20	0.33

▸	SHH	Q15465	2/20	0.33

▸	FGF1	P05230	2/20	0.33

▸	F2	P00734	1/20	0.33

▸	FGF2	P09038	1/20	0.33

▸	IFNG	P01579	1/20	0.33

▸	PF4	P02776	1/20	0.33

▸	SELP	P16109	1/20	0.33

▸	BMP6	P22004	1/20	0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL16418346	0.95	F10 (0.55)	F10BDNFPTNMDKSERPINC1
SCHEMBL16425626	0.95	F10 (0.54)	F10BDNFPTNMDKSERPINC1
SCHEMBL16425619	0.94	F10 (0.57)	F10BDNFPTNMDKSERPINC1
SCHEMBL16425624	0.93	F10 (0.51)	F10BDNFPTNMDKSERPINC1
SCHEMBL16425610	0.92	F10 (0.54)	F10BDNFPTNMDKSERPINC1
SCHEMBL16425606	0.91	F10 (0.52)	F10BDNFPTNMDKSERPINC1
SCHEMBL16425623	0.91	F10 (0.49)	F10BDNFPTNMDKSERPINC1
SCHEMBL16425627	0.91	F10 (0.51)	F10BDNFPTNMDKSERPINC1
SCHEMBL16425612	0.90	F10 (0.58)	F10BDNFPTNMDKSERPINC1
SCHEMBL16418325	0.90	F10 (0.60)	F10BDNFPTNMDKSERPINC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-20150031866-A1	PROCESS FOR THE PRODUCTION OF FONDAPARINUX SODIUM	SCINOPHARM TAIWAN, LTD. (TW)	2015-01-29	—	—	US	disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

Patent	Title	Text reads most about	Predicted target · text-rank
US-20150031866-A1	PROCESS FOR THE PRODUCTION OF FONDAPARINUX SODIUM	PF4, ABCC4, KCNH1	F10 119/4885BDNF 4813/4885PTN 4026/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.